Talimogene laherparepvec Injection and Immunodeficiency
Result of checking the interaction of drug Talimogene laherparepvec Injection and disease Immunodeficiency for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Talimogene laherparepvec is a live, attenuated herpes simplex virus. Its use is contraindicated in immunocompromised patients as they may be at risk of life-threatening disseminated herpetic infection. Do not administer talimogene laherparepvec to immunocompromised patients, including those with a history of primary or acquired immunodeficient states, leukemia, lymphoma, AIDS or other clinical manifestations of infection with human immunodeficiency viruses, and those on immunosuppressive therapy.
Generic Name: talimogene laherparepvec
Brand Name: Imlygic
Synonyms: Talimogene laherparepvec, Talimogene Laherparepvec